Table 4

Proportion of the phenotypic variance explained by the markers significantly associated with the evaluated traits

Trait1

Family

LG

Method2 and

QTL position (cM)

Marker3

Marker

position (cM)4

R2 (%)


Re

FamAS-2

4

LR: 0/ML: 10

Sma-USC47

0.00

7.4

FamAS-3

6

LR: 0/ML: 26

Sma-USC147

4.52

16.2

FamAP

5

ML: 21

SmaUSC-E30

0.00

8.9

9

LR: 31/ML: 38

SmaUSC-E23

30.75

10.5

SmaUSC-E41

45.68

12.4

Sma-USC21

53.91

11.6

16

ML: 35

Sma-USC256

32.75

13.6

Su

FamAS-2

4

LR: 0/ML: 10

Sma-USC47

0.00

8.1

11

LR: 43

Sma-USC158

23.39

10.1

FamAS-3

6

LR: 0/ML: 26

Sma-USC147

4.52

16.8

FamAP

5

ML: 19

SmaUSC-E30

0.00

8.9

9

LR: 31/ML: 36

SmaUSC-E23

30.75

12.3

SmaUSC-E41

45.68

12.8

Sma-USC21

53.91

12.0

16

ML: 36

Sma-USC256

32.75

12.4


1Re: resistance; Su: survival.

LG: linkage group.

2LR: linear regression method; ML: maximum likelihood method;

3BLAST annotation [17] was only recorded for Sma-USC23 (3-Hydroxibutirate dehydrogenase type 2) and Sma-USC41 (Helicase with zinc finger domain).

4Marker position in centimorgan (cM) within the genetic map by Bouza et al. [17].

R2 (%): proportion of the explained phenotypic variance.

Rodríguez-Ramilo et al. BMC Genomics 2011 12:541   doi:10.1186/1471-2164-12-541

Open Data